TurtleTree Obtains First-Ever Self-GRAS Status for Precision Fermentation-Derived Lactoferrin
Singaporean biotech TurtleTree claims that it has obtained the world’s first self-GRAS status (generally recognized as safe) by the FDA for a precision fermentation-derived lactoferrin, making it also the first Singaporean company to obtain self-GRAS for a synbio protein. This status confirms that TurtleTree’s animal-free lactoferrin is safe for human consumption, allowing the company to commercialize it in the USA. In May, the company unveiled the protein, branded under L+, claiming it as the world’s first animal-free lactoferrin. TurtleTree announced that it will supply LF+ for infant formulas, plant-based dairy, and sports nutrition products, including protein powders, functional beverages, meal replacement alternatives, and multivitamins, expecting profitability in 2024. The biotech company also announced that multiple clients have shown interest in buying a $500 million value of animal-free lactoferrin …